about
Nicorandil protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis.Exendin-4 protects bone marrow-derived mesenchymal stem cells against oxygen/glucose and serum deprivation-induced apoptosis through the activation of the cAMP/PKA signaling pathway and the attenuation of ER stressMacrophage migration inhibitory factor promotes cardiac stem cell proliferation and endothelial differentiation through the activation of the PI3K/Akt/mTOR and AMPK pathways.Chronic total occlusion is associated with a higher incidence of malapposition and uncovered stent struts: OCT findings at 6 months following DES implantation.Chronic kidney disease predicts coronary plaque vulnerability: an optical coherence tomography study.Statin-induced improvements in vulnerable plaques are attenuated in poorly controlled diabetic patients with coronary atherosclerosis disease: a serial optical coherence tomography analysis.Comparison of optical coherence tomography and intravascular ultrasound for evaluation of coronary lipid-rich atherosclerotic plaque progression and regression.Insights into the spatial distribution of lipid-rich plaques in relation to coronary artery bifurcations: an in-vivo optical coherence tomography study.Cables1 Inhibits Proliferation and Induces Senescence by Angiotensin II via a p21-Dependent Pathway in Human Umbilical Vein Endothelial Cells.Comparison of Intensive Versus Moderate Lipid-Lowering Therapy on Fibrous Cap and Atheroma Volume of Coronary Lipid-Rich Plaque Using Serial Optical Coherence Tomography and Intravascular Ultrasound Imaging.Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion (the EROSION study).Interleukin-35 promotes early endothelialization after stent implantation by regulating macrophage activation
P50
Q35849951-055F0166-D34A-41B9-B861-B44D397447EBQ35943572-4A6CE77B-A241-4F3C-9A89-D5F869E5E0B5Q36791222-2DFF2C44-F5E0-49CD-A6DD-92E549E87C4BQ40285456-485FF8E0-30EC-4F26-B700-D5D5D339900FQ40439382-5E0450CD-CB30-4460-A73E-757E5F37F439Q40596277-BBF66FF2-7E27-4C54-B703-AF68692733DAQ41016170-F62EF3E5-8939-4A8D-A1C3-850317A1A0CEQ44553502-3419B93A-BBF0-4139-8794-43C69B5CA060Q51171117-F83CF777-D35E-4E88-B3D0-E1846BF10E84Q53206091-E8E8855B-1A89-4643-B082-F8B5794E0C76Q53217243-8F2CF20B-C3B6-4135-9C2A-0A0A8EE56726Q92635236-5882E3E8-2E7A-4389-A15F-CDD104B1D9E8
P50
description
researcher (ORCID 0000-0002-2045-8567)
@en
name
Bo Yu
@en
type
label
Bo Yu
@en
prefLabel
Bo Yu
@en
P31
P496
0000-0002-2045-8567